I agree that the science is too good....as that article said there are four shots on goal and they will be coming soon. My favorite is B-OM because it is easily administered, there is an unmet medical need and it may help a cancer treatment work properly if OM does interrupt treatment. I have to believe an oncology company would look at this and want to latch onto it if it would help their revenues and patients. The other B,P and K indications aren't too bad either......